高通量透析联合左卡尼汀对血液透析患者微炎症状态的影响被引量：7

下载PDF

导出

摘要维持性血液透析（maintenance hemodialysis, MHD）患者长期存在的微炎症状态是发生心血管疾病的重要病理学基础,而心血管事件是尿毒症患者最主要的死亡原因[1]。如何有效控制 MHD患者微炎症状态已成为血液透析过程中需要考虑的重要因素。本研究采取高通量血液透析（high- flux hemodialysis HFHD）联合左卡尼汀（L-carnitine）的疗法,观察其对维持性血液透析患者微炎症的影响。

作者周波徐霞

机构地区湖北省十堰鄖县人民医院肾内科湖北省十堰鄖县疾病预防控制中心

出处《临床肾脏病杂志》 2014年第8期504-505,共2页 Journal Of Clinical Nephrology

关键词维持性血液透析患者微炎症状态左卡尼汀高通量透析高通量血液透析病理学基础心血管疾病尿毒症患者

分类号 R459.5 [医药卫生—治疗学]

引文网络
相关文献

参考文献11

1Errier N, Senecal L, Dupuy AM, et al. Association between no- vel in dices of malnutrition-inflammation complex syndrome and cardiobascular disease in hemodialysis patients. Hemodial Int,2005,9: 159-168. 被引量：1
2Pisetkul C, Chanchairujira K, Chotipanvittayakul N, et al. Mal- nutrition-in-flammation score associated with atheroselerosis, inflammation and short-term outcome in hemodialysis patients. J Med Assoc Tha,2010,93 Suppl 1 : 147-156. 被引量：1
3Calo LA, Bertipaglia L, Pagnin E. Antioxidants, carnitine and erythropoietin. G Ital Nefrol, 2006 Jan-Feb, 23 Suppl 34:47- 50. 被引量：1
4Tsirpanlis G, Chatzipanagiotou S, Nicolaou C. Microinflamma- tion versus inflammation in chronic renal failure patients. Kid- ney Int, 2004,66 : 2093. 被引量：1
5蓝天座,于黔,闵亚丽,吴欣,赵素云,娄澜.高通量透析对维持性血液透析患者微炎症状态和营养状态的影响[J].中国药业,2011,20(9):65-66. 被引量：22
6Ates K, Vilmaz O, Kutlay S, et al. Serum C-reactive protein level is associated with renal function and it affects echocardio- graphic cardiovascular disease in pre-dialysis patients. Nephron Clin Pratt, 2005,101 : c190-c197. 被引量：1
7Davenport A. The role of dialyzer membrane flux in Bio-incom- patibility. Hemodial Int, 2008 , 12(Suppl 2) : 29-33. 被引量：1
8蔡砺,刘惠兰,吴华,李冀军,徐丰博,汤天清,殷培,鲍云飞,程叙扬,左力.高通量血液透析可以有效地清除β_2微球蛋白和改善维持性血液透析患者的慢性炎症状态[J].中国血液净化,2010,9(1):25-28. 被引量：79
9Korish AA. Oxidative stress and nitric oxide deficiency in in- flammation of chronic renal failure. Possible preventive role of L- arginine and multiple antioxidants. Saudi Med J, 2009, Sep,30:1150-1157. 被引量：1
10Sener G,Paskaloglu K, Satiroglu H, et al. L-camitine amelio- rates oxidative damage due to chronic renal failure in rats. J Cardiovasc Pharmacol, 2004, May, 43 : 698-705. 被引量：1

二级参考文献19

1汪伟,陈家林,张爱萍.尿毒症血液透析患者炎症反应与营养状态及贫血的关系[J].实用心脑肺血管病杂志,2004,12(4):212-214. 被引量：26
2YoshitioM, Kuhlmann MK, Kotanko P, et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality [J]. J Am Soc Nephrol, 2006, 17: 3510-3519. 被引量：1
3Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: Classification, concentration, and interindividual variability[J]. Kidney Int, 2003, 63:1934- 1943. 被引量：1
4Vanholder R, Meert N, Schepers E, et al. Uremic toxins: Do we know enough to explain uremia[J]. Blood Purif, 2008, 26: 77-81. 被引量：1
5Gejyo F, Yamada T, Odani S, et al. A new form of amyloid protein associated with chronic hemodialysis was identi fled as beta 2 microglobulin[J]. Biochem Biophys Res Commun, 1985, 129:701 -706. 被引量：1
6Bember LM, Jaber BL. Dialysis- ReLated Amyloidosis: Late Finding or Hidden Epidemic[J]. Seminars in Dialysis, 2006, 19:105-109. 被引量：1
7Cheung AK, Rocco MV, gan G, et al. Serum β2- microglobulin levels predict mortality in dialysis patients: results of the HEMO study[J]. J Am Soc Nephrol, 2006, 17:546- 555. 被引量：1
8Okuno S, Ishimura E, Rohno K, et al. Serum β2-microglobulin level is a significant predictor of mortality in mainte nance haemodialysis patients[J]. Nephrol Diat Transplant, 2009, 24: 571-577. 被引量：1
9Nakai S, Iseki K, Tabei K, et al. Outcomes of hermdiafiltration based on Japanese dialysis patient registry[J]. Am J Kidney Disease, 2001, 38: S212-216. 被引量：1
10Furuya R, Kumaqai B, Takahashi M, et al. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients[J]. Blood Purif, 2005,23:311- 316. 被引量：1